Association Between Early Treatment With Tocilizumab and Mortality Among Critically Ill Patients With COVID-19

Overview of attention for article published in JAMA Internal Medicine, January 2021

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (99th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 7 public wall posts from 2 users.

This cohort study assesses mortality rates among patients with COVID-19 admitted to intensive care who were treated with…

This cohort study assesses mortality rates among patients with COVID-19 admitted to intensive care who were treated with…

This cohort study assesses mortality rates among patients with COVID-19 admitted to intensive care who were treated with…

This cohort study assesses mortality rates among patients with COVID-19 admitted to intensive care who were treated with…

https://bit.ly/3sBJXe8

Among critically ill patients with #COVID19, early treatment with tocilizumab may reduce mortality, although the findings may…

Among critically ill patients with #COVID19, early treatment with tocilizumab may reduce mortality, although the findings may…